Next Article in Journal
Peculiar Characteristics of Arteriovenous Malformations Arising in the Galenic Region
Previous Article in Journal
Multidetector Computed Tomography with Dedicated Protocol for Breast Cancer Locoregional Staging: Feasibility Study
Previous Article in Special Issue
Growth Plate Pathology in the Mucopolysaccharidosis Type VI Rat Model—An Experimental and Computational Approach
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diagnostics
Volume 10
Issue 7
10.3390/diagnostics10070480
diagnostics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Diagnostics 2020, 10(2), 108.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Barak, S. et al. “Long-Term Outcomes of Early Enzyme Replacement Therapy for Mucopolysaccharidosis IV: Clinical Case Studies of Two Siblings”. Diagnostics 2020, 10, 108

by
Sharon Barak
1,2,*,
Yair Anikster
3,4,5,
Ifat Sarouk
6,7,
Eve Stern
8,
Etzyona Eisenstein
1,
Tamar Yissar
1,
Nir Sherr-Lurie
9,
Annick Raas-Rothschild
10,11 and
Dafna Guttman
1
1
Department of Pediatric Rehabilitation, Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center, Ramat-Gan 5265601, Israel
2
Kaye Academic College of Education, M.Ed. Programs, Beer-Sheva 8414201, Israel
3
The Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
4
Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center, Ramat Gan 5265601, Israel
5
Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Ramat Gan 5265601, Israel
6
The National AT Center, Chaim Sheba Medical Center, Ramat Gan 5265601, Israel
7
The Pediatric Pulmonology Unit, Chaim Sheba Medical Center, Edmond and Lilly Safra Children Hospital, Tel HaShomer, Ramat Gan 5265601, Israel
8
Pediatric Endocrine and Diabetes Unit, Chaim Sheba Medical Center, Edmond and Lily Safra Children’s Hospital, Ramat-Gan 5265601, Israel
9
Pediatric Orthopedic Unit, Edmond and Lilly Safra Children Hospital, Chaim Sheba Medical Center, Ramat Gan 5265601, Israel
10
Institute of Rare Diseases, Edmond and Lily Safra Children’s hospital, Chaim Sheba Medical Center, Ramat Gan 5265601, Israel
11
The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv postcode Israel, Ramat Aviv 69978, Israel
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
Diagnostics 2020, 10(7), 480; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10070480
Published: 14 July 2020
(This article belongs to the Special Issue Mucopolysaccharidoses: Diagnosis, Treatment, and Management)
Versions Notes
The authors wish to make the following correction to this paper [1]:
In the first paragraph of the Results section: “P1 and P2 started ERT with elosulfase alfa (VIMIZIM® by BioMarin©) 5 months post-diagnosis at age 4.5 years and 11 months, respectively, with an intravenous dose of 1.0 mg/kg/week.” The value of the dose is 1.0 mg/kg/week but should be corrected to 2.0 mg/kg/week.
These changes have no material impact on the conclusions of our paper. We apologize to our readers.

Reference

  1. Barak, S.; Anikster, Y.; Sarouk, I.; Stern, E.; Eisenstein, E.; Yissar, T.; Sherr-Lurie, N.; Raas-Rothschild, A.R.; Guttman, D. Long-Term Outcomes of Early Enzyme Replacement Therapy for Mucopolysaccharidosis IV: Clinical Case Studies of Two Siblings. Diagnostics 2020, 10, 108. [Google Scholar] [CrossRef] [PubMed] [Green Version]

Share and Cite

MDPI and ACS Style

Barak, S.; Anikster, Y.; Sarouk, I.; Stern, E.; Eisenstein, E.; Yissar, T.; Sherr-Lurie, N.; Raas-Rothschild, A.; Guttman, D. Correction: Barak, S. et al. “Long-Term Outcomes of Early Enzyme Replacement Therapy for Mucopolysaccharidosis IV: Clinical Case Studies of Two Siblings”. Diagnostics 2020, 10, 108. Diagnostics 2020, 10, 480. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10070480

AMA Style

Barak S, Anikster Y, Sarouk I, Stern E, Eisenstein E, Yissar T, Sherr-Lurie N, Raas-Rothschild A, Guttman D. Correction: Barak, S. et al. “Long-Term Outcomes of Early Enzyme Replacement Therapy for Mucopolysaccharidosis IV: Clinical Case Studies of Two Siblings”. Diagnostics 2020, 10, 108. Diagnostics. 2020; 10(7):480. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10070480

Chicago/Turabian Style

Barak, Sharon, Yair Anikster, Ifat Sarouk, Eve Stern, Etzyona Eisenstein, Tamar Yissar, Nir Sherr-Lurie, Annick Raas-Rothschild, and Dafna Guttman. 2020. "Correction: Barak, S. et al. “Long-Term Outcomes of Early Enzyme Replacement Therapy for Mucopolysaccharidosis IV: Clinical Case Studies of Two Siblings”. Diagnostics 2020, 10, 108" Diagnostics 10, no. 7: 480. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10070480

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop